NIDCR to Fund Research into Basis of Oral Cancer Initiating Cells | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Dental and Craniofacial Research plans to award $1.5 million next year to fund researchers delving into the molecular and cell-level biology of cancer initiating cells (CICs), also called cancer stem cells, which may be involved in oral cancers.

In a pair of new RFAs, the institute said that recent evidence that CICs play a functional role in tumors in other areas of the body has led to the hypothesis that they may enable some cancers to evade therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.

Sponsored by
Personal Genome Diagnostics

This online seminar will discuss the application of circulating tumor DNA (ctDNA) sequencing to evaluate the emergence of resistance mutations during therapy.